metastatic Mismatch repair deficient (dMMR) solid tumors

DBCOND0144303Neoplasms

metastatic Mismatch repair deficient (dMMR) solid tumors is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Classified under
Indicated drugs

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in

Which approved drugs for metastatic Mismatch repair deficient (dMMR) solid tumors share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In